$AVBH

Avidbank Holdings EVP Wasson sells $331,400 in company stock

Avidbank Holdings (NASDAQ:AVBH) EVP and Chief Revenue Officer Arthur Wasson sold 10,000 shares on Aug. 14, 2026 at $33.14 each for $331,400. After the sale he owned 10,451 shares. The stock trades around $32.88. The article also cites AVBH Q2 2026 results: adjusted EPS $0.76 vs $0.8275 expected, revenue $29.73M vs forecast, plus a litigation charge and higher funding costs.

Original reporting
Published Aug 15, 2026, 5:53 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 16, 2026, 6:40 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$AVBH
Neutral
medium confidence
Mentioned
$AVBH
Relevance
4/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$AVBHNeutralLow
01

Why it matters

For traders, the actionable element is the disclosed insider sale price and size. The earnings section provides mixed signals (EPS miss, revenue beat, NIM narrowing, credit quality improving) but does not clearly state that new guidance or a new filing was released in this article.

02

Market read

Insider selling can slightly pressure sentiment, but the article lacks a new fundamental trigger beyond the transaction disclosure and a recap of recent quarter metrics.

03

What to watch

The article mentions a litigation charge and higher funding costs, which could be the real driver of risk, but it does not quantify duration or resolution timeline.

Relevance 4/10Novelty 3/10Timing: Aug. 14 insider sale disclosed on Aug. 15; stock trading around $32.88

Background

The piece centers on an insider stock sale by Avidbank Holdings EVP Arthur Wasson and summarizes the company’s latest quarter results and outlook framing.

Company-level read

Ticker impact

$AVBHNeutralMedium confidence
Context

Avidbank EVP Arthur Wasson sold 10,000 shares at $33.14 on Aug. 14, 2026, totaling $331,400, while AVBH trades near $32.88.

Expected impact

Limited near-term impact; insider selling can add mild caution, but the piece lacks a fresh catalyst like guidance or a new filing.

Evidence & confidence

The only new, concrete item is the insider transaction size and price. The earnings discussion is presented as recent context, not as a newly released datapoint in this article.

Market effects

No sector-wide signal; the story is company-specific to a small bank and its SBA lending expansion.

None indicated.

None indicated.

Counterpoint

The insider sale may be routine diversification or tax-related, so it should not be over-weighted versus the company’s operating improvements like lower non-performing loans.

Key entities

  • Avidbank Holdings, Inc.

    NASDAQ-listed bank where EVP Arthur Wasson sold 10,000 shares at $33.14; article also summarizes Q2 2026 results and SBA lending expansion.

  • Arthur Wasson

    Executive Vice President and Chief Revenue Officer who sold $331,400 of AVBH stock on Aug. 14, 2026.

Related articles

$AVBHMed

Avidbank Holdings, Inc. Announces Financial Results for the Second Quarter of 2026

Avidbank Holdings (NASDAQ:AVBH) reported Q2 2026 net income of $7.6 million, or $0.71 diluted EPS, down from $9.0 million in Q1 2026 and $5.8 million in Q2 2025. The quarter included a $2.6 million litigation settlement expense and about $1.3 million in BOLI income. Adjusted net income was $8.2 million, or $0.76 per share. Loans and deposits rose; NPLs were 0.65% and net interest margin fell to 4.26%.

$AVBHMed

Avidbank Holdings, Inc. (AVBH): Results of Operations and Financial Condition

Avidbank Holdings, Inc. (AVBH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_964348.htm EXHIBIT 99.1 ex_964348.htm Exhibit 99.1 FOR IMMEDIATE RELEASE PRESS RELEASE Avidbank Holdings, Inc. Announces Financial Results for the Second Quarter of 2026 SAN JOSE, CA (ACCESS Newswire) – July 23, 2026 – Avidbank Holdings, Inc. (NASDAQ: AVBH) (the “Com

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.

$XOMMed

Piper Sandles Sees ExxonMobil (XOM) Heading Toward New Highs

Piper Sandler raised its price target for ExxonMobil (XOM) to $185, citing strong fundamentals, cost savings, and growth in Guyana. XOM's Q2 earnings beat expectations, with high free cash flow and shareholder returns. However, risks include exposure to Middle East conflicts and potential crude price normalization. XOM's stock has risen 30% in 2026, with a 16% upside implied by the new target.